Medical Devices - Singapore, , Singapore
The ICP - Innovators Commercialisation Program is led by Asia Research & Innovation Alliance (ARIA)'s Institute of Healthtech Excellence, in collaboration with the National University Hospital of Singapore (NUHS) - Centre for Innovation in Healthcare (CIH). ICP program helps innovators to accelerate their product validation and expansion into Singapore.A global team of healthcare professionals and clinicians will offer clinical validation and venture building support to grow your business in Singapore and the region over a 6 months program. Completion of the ICP program will allow innovators access to venture investment of up to USD1,000,000.BENEFITS OF THE PROGRAM- Venture Funding of $1million Dollars- Establish Global HQ in Singapore with Regulatory Incentives- Fast Track to Clinical Adoption and Trials in Singapore and across Asia- Network with the largest Medtech companies in the world- Access to a Global Committee of Medical Industry Professionals PROGRAM THEMES1. Improving Users Lifespans and Quality of Life2. Enabling Seamless Delivery of High-Quality Healthcare3. Digitalisation of Hospital Systems4. Enhancing Women's and Children's Health OutcomesPROGRAM STRUCTUREThe program is split into 3 phases of 6 months in total: 1. Phase 1 covers the Clinical Validation phase with the NUHS-CIH team, with access to 3 major hospitals and 8 polyclinics in Singapore.2. Phase 2 is the product actuation process with the venture building team comprising of top medical industry professionals.3. Phase 3 is the venture funding and scale-up process, with key support provided in operational rolesSELECTION CRITERIA1. Prototypes have been developed2. Patents approved or pending approval3. Obtained preliminary clinical trial data and/or published in research publications4. Business plans developed HOW DO YOU APPLY?Send your 1 slide business plan to connect@ariainstitute.org OR apply through the website https://www.ariainstitute.org/icp
Varnish
Wix
Google Cloud Hosting
Mobile Friendly